Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASK120067 in EGFR T790M-positive NSCLC (Phase I/II, single arm)
CTR20171639Phase 2Completed
- Sponsor
- Jiangsu Aosaikang Pharmaceutical Co., Ltd.
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of limertinib in non-small cell lung cancer (NSCLC), sponsored by Jiangsu Aosaikang Pharmaceutical Co., Ltd.. Started Apr 2018; status: completed.
02
Drugs
limertinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on CTR20171639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171639.